All Insights
Showing 85 - 96 of 240
Life Sciences and Healthcare
Medical device, clinical trial and safety rules reforms could boost UK life sciences
As the economy falters and NHS waiting lists grow, 2021 legislation offers wide powers to reform product rules and spur
Intellectual property
Queen's Speech bill aims to bring gene-edited plants and animals to market
The Genetic Technology (Precision Breeding) Bill seeks to simplify the regulatory regime for precision-bred plants and animals
Life Sciences and Healthcare
New WTO Covid-19 vaccine IP waiver proposed
A new vaccine IP waiver proposal has been published by the WTO Director-General following informal negotiations between the EU, India
IT and data
Cyber breach – The French Conseil d’Etat confirms the CNIL decision against Optical Center (250.000 Euros fine)
Optical Center company suffered a cyber-attack of its e-commerce website on January 2019 which resulted in several complaints of prospects
Life Sciences and Healthcare
Health data leak: 1.5 million euro fine against Dedalus Biologie
Following a massive health data leak disclosed in the press concerning nearly 500,000 persons in February 2021, the French Authority
Life Sciences and Healthcare
Italy is finally poised to get a law on transparency in the healthcare sector
Sunshine Act will oblige Italian pharmas to respect the obligations of transparency regardless of industry codes The Italian Parliament is
Life Sciences and Healthcare
The transfer of Data of non-profit clinical trials to pharmaceutical companies is now allowed in Italy
Previous restrictions on data transfer are lifted, enabling more investment - some clarification on practical issues is awaited In the
Life Sciences and Healthcare
Compassionate Use in Europe
As European countries implement compassionate use programmes in different ways, we offer a guide to the different approaches taken within
Intellectual property
European Commission proposes harmonisation of patent law with unitary SPCs and single procedure for grant
The European Commission has launched a call for evidence on its proposal to create a unitary supplementary protection certificate and/or
Life Sciences and Healthcare
Farmindustria releases updated Code Of Ethics
Italy's association for pharmaceutical companies has amended its Code of Ethics with 4 new articles on PSP and on the
Life Sciences and Healthcare
Is Italy's new law on rare diseases a starting or end point?
Pharmaceutical companies will need to take note of new rules that include funding for research and tax incentives After a
Intellectual property
Vagisil versus Vagisan and prefixes: takeaways for healthcare brand owners
Vagisan was found by the High Court to infringe the Vagisil trade mark and a proposed rebrand to 'Dr Wolff's
